← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Soymeds, Inc.
Davidson, NC
$4,889,235
Total funding
8
Grants
Funding over time
peak $685.4K · FY2007–22$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$4,889,235 · 8
By mechanism
R44$2,219,392 · 2
R43$1,039,494 · 3
R42$877,379 · 1
R01$552,000 · 1
R41$200,970 · 1
Investigators at Soymeds, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Platform for practical delivery of oral autoantigens as co-therapies for neurological disease$548,420
R44 · FY2016 · NS
Platform for practical delivery of oral autoantigens as co-therapies for neurological disease$495,665
R44 · FY2017 · NS
A Novel Therapy for Staphylococcal Enterotoxin B Poisoning$445,716
R42 · FY2009 · AI
A Novel Therapy for Staphylococcal Enterotoxin B Poisoning$431,663
R42 · FY2010 · AI
Improved diagnostic and monitoring assays for thyroid cancer$393,458
R44 · FY2015 · CA
Improved diagnostic and monitoring assays for thyroid cancer$391,627
R44 · FY2013 · CA
Improved diagnostic and monitoring assays for thyroid cancer$390,222
R44 · FY2014 · CA
Oral autoantigen therapy for the treatment of Multiple Sclerosis$294,973
R43 · FY2022 · AI
Oral autoantigen therapy for the treatment of Multiple Sclerosis$288,580
R43 · FY2021 · AI
Platform for practical delivery of oral autoantigens as co-therapies for neurolog$276,000
R01 · FY2015 · NS
Platform for practical delivery of oral autoantigens as co-therapies for neurolog$276,000
R01 · FY2014 · NS
Novel therapy for treating Multiple Sclerosis$239,720
R43 · FY2009 · NS
Improved diagnostic and monitoring assays for thyroid cancer$216,221
R43 · FY2010 · CA
A Novel Therapy for Staphyloccocal Enterotoxin B poisoning$200,970
R41 · FY2007 · AI